Biotech · Private company · San Diego, CA, US
Novomedix, Inc.
Track this companyFree. Adds Novomedix, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
NIH awards5
- Novel small molecule for the prevention and treatment of DMD cardiomyopathyFiscal year 2026 · $356KNIH RePORTER 1R43HL182659-01A1 · fetched Nov 12, 2026
- Arthrofibrosis control using small molecule inhibitors of interleukin-11Fiscal year 2025 · $314.4KNIH RePORTER 1R43AR086064-01 · fetched Nov 12, 2026
- NOVOMEDIX TRANSITION TO PHASE II - THERAPEUTICS SBIR CONTRACTSBIR PHASE II - ENHANCED OVERALL SURVIVAL IN HIGH-RISK PEDIATRIC SOLID TUMORS USING A NOVEL ORAL SMALL MOLECULEFiscal year 2025 · $3MNIH RePORTER 75N91025C00051-0-9999-1 · fetched Nov 12, 2026
- Novel oral small molecules for progressive pulmonary fibrosisFiscal year 2024 · $306.9KNIH RePORTER 1R43HL176343-01 · fetched Nov 12, 2026
- Definitive (GLP) Toxicity and Toxicology Studies for a Novel Small Molecule for Protection Against Cardiotoxicity in Triple Negative Breast CancerFiscal year 2024 · $500KNIH RePORTER 1SB1HL174247-01 · fetched Nov 12, 2026